Table of Contents
Hepatitis Research and Treatment
Volume 2013 (2013), Article ID 601290, 7 pages
http://dx.doi.org/10.1155/2013/601290
Review Article

Postinfantile Giant Cell Hepatitis: An Etiological and Prognostic Perspective

1Department of Pathology, Institute of Liver and Biliary Sciences (ILBS), D-1 Vasant Kunj, New Delhi 110070, India
2Department of Hepatology, Institute of Liver and Biliary Sciences (ILBS), New Delhi 110070, India

Received 16 January 2013; Revised 5 February 2013; Accepted 7 February 2013

Academic Editor: Tatehiro Kagawa

Copyright © 2013 Chhagan Bihari et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. S. J. Johnson, J. Mathew, R. N. M. MacSween, M. K. Bennett, and A. D. Burt, “Post-infantile giant cell hepatitis: histological and immunohistochemical study,” Journal of Clinical Pathology, vol. 47, no. 11, pp. 1022–1027, 1994. View at Google Scholar · View at Scopus
  2. K. Devaney, Z. D. Goodman, and K. G. Ishak, “Postinfantile giant-cell transformation in hepatitis,” Hepatology, vol. 16, no. 2, pp. 327–333, 1992. View at Publisher · View at Google Scholar · View at Scopus
  3. M. J. Phillips, L. M. Blendis, S. Poucell et al., “Sporadic hepatitis with distinctive pathological features, a severe clinical course, and paramyxoviral features,” The New England Journal of Medicine, vol. 324, no. 7, pp. 455–460, 1991. View at Google Scholar · View at Scopus
  4. J. Y. N. Lau, G. Koukoulis, G. Mieli-Vergani, B. C. Portmann, and R. Williams, “Syncytial giant-cell hepatitis—a specific disease entity?” Journal of Hepatology, vol. 15, no. 1-2, pp. 216–219, 1992. View at Publisher · View at Google Scholar · View at Scopus
  5. L. Gabor, K. Pal, and S. Zsuzsa, “Giant cell hepatitis in adults,” Pathology and Oncology Research, vol. 3, no. 3, pp. 215–218, 1997. View at Google Scholar
  6. M. Fraquelli, A. Colli, M. Cocciolo, and D. Conte, “Adult syncytial giant cell chronic hepatitis due to herbal remedy,” Journal of Hepatology, vol. 33, no. 3, pp. 505–508, 2000. View at Publisher · View at Google Scholar · View at Scopus
  7. T. Tordjmann, S. Grimbert, C. Genestie et al., “Adult multi-nuclear cell hepatitis. A study in 17 patients,” Gastroenterologie Clinique et Biologique, vol. 22, no. 3, pp. 305–310, 1998. View at Google Scholar · View at Scopus
  8. V. Singh, M. Rudraraju, E. J. Carey et al., “An unusual occurrence of giant cell hepatitis,” Liver Transplantation, vol. 15, no. 12, pp. 1888–1890, 2009. View at Publisher · View at Google Scholar · View at Scopus
  9. J. Hartl, R. Buettner, F. Rockmann et al., “Giant cell hepatitis: an unusual cause of fulminant liver failure,” Zeitschrift fur Gastroenterologie, vol. 48, no. 11, pp. 1293–1296, 2010. View at Publisher · View at Google Scholar · View at Scopus
  10. H. Hayashi, R. Narita, M. Hiura et al., “A case of adult autoimmune hepatitis with histological features of giant cell hepatitis,” Internal Medicine, vol. 50, no. 4, pp. 315–319, 2011. View at Publisher · View at Google Scholar · View at Scopus
  11. K. Tajiri, Y. Shimizu, Y. Tokimitsu et al., “An elderly man with syncytial giant cell hepatitis successfully treated by immunosuppressants,” Internal Medicine, vol. 51, no. 16, pp. 2141–2144, 2012. View at Google Scholar
  12. K. Dohmen, S. Ohtsuka, H. Nakamura et al., “Post-infantile giant cell hepatitis in an elderly female patient with systemic lupus erythematosus,” Journal of Gastroenterology, vol. 29, no. 3, pp. 362–368, 1994. View at Publisher · View at Google Scholar · View at Scopus
  13. M. Gorelik, R. Debski, and H. Frangoul, “Autoimmune hemolytic anemia with giant cell hepatitis: case report and review of the literature,” Journal of Pediatric Hematology/Oncology, vol. 26, no. 12, pp. 837–839, 2004. View at Google Scholar · View at Scopus
  14. P. Vajro, F. Migliaro, C. Ruggeri et al., “Life saving cyclophosphamide treatment in a girl with giant cell hepatitis and autoimmune haemolytic anaemia: case report and up-to-date on therapeutical options,” Digestive and Liver Disease, vol. 38, no. 11, pp. 846–850, 2006. View at Publisher · View at Google Scholar · View at Scopus
  15. A. R. Perez-Atayde, S. M. Sirlin, and M. Jonas, “Coombs-positive autoimmune hemolytic anemia and postinfantile giant cell hepatitis in children,” Pediatric Pathology, vol. 14, no. 1, pp. 69–77, 1994. View at Google Scholar · View at Scopus
  16. U. Protzer, H. P. Dienes, L. Bianchi et al., “Post-infantile giant cell hepatitis in patients with primary sclerosing cholangitis and autoimmune hepatitis,” Liver, vol. 16, no. 4, pp. 274–282, 1996. View at Google Scholar · View at Scopus
  17. M. P. Stoffel, H. M. Steffen, V. Dries, H. P. Dienes, and C. A. Baldamus, “Acute exacerbation overlapping autoimmune liver disease with development of giant cell hepatitis after 14 years' disease duration,” Journal of Internal Medicine, vol. 244, no. 4, pp. 355–356, 1998. View at Google Scholar · View at Scopus
  18. J. Estradas, V. Pascual-Ramos, B. Martínez et al., “Autoimmune hepatitis with giant-cell transformation,” Annals of Hepatology, vol. 8, no. 1, pp. 68–70, 2009. View at Google Scholar
  19. J. Koskinas, M. Deutsch, C. Papaioannou, G. Kafiri, and S. Hadziyannis, “Post-infantile giant cell hepatitis associated with autoimmune hepatitis and polyarteritis nodosa,” Scandinavian Journal of Gastroenterology, vol. 37, no. 1, pp. 120–123, 2002. View at Publisher · View at Google Scholar · View at Scopus
  20. J. Labowitz, S. Finklestein, and M. Rabinovitz, “Postinfantile giant cell hepatitis complicating ulcerative colitis: a case report and review of the literature,” The American Journal of Gastroenterology, vol. 96, no. 4, pp. 1274–1277, 2001. View at Publisher · View at Google Scholar · View at Scopus
  21. N. Watanabe, S. Takashimizu, K. Shiraishi et al., “Primary biliary cirrhosis with multinucleated hepatocellular giant cells: implications for pathogenesis of primary biliary cirrhosis,” The European Journal of Gastroenterology and Hepatology, vol. 18, no. 9, pp. 1023–1027, 2006. View at Publisher · View at Google Scholar · View at Scopus
  22. M. Rabinovitz and A. J. Demetris, “Postinfantile giant cell hepatitis associated with anti-M2 mitochondrial antibodies,” Gastroenterology, vol. 107, no. 4, pp. 1162–1164, 1994. View at Google Scholar · View at Scopus
  23. Z. Ben-Ari, E. Broida, Y. Monselise et al., “Syncytial giant-cell hepatitis due to autoimmune hepatitis type II (LKM1+) presenting as subfulminant hepatitis,” The American Journal of Gastroenterology, vol. 95, no. 3, pp. 799–801, 2000. View at Publisher · View at Google Scholar · View at Scopus
  24. P. Kinra and B. M. John, “Hepatitis—a induced non infantile giant cell hepatitis,” Medical Journal Armed Forces India, vol. 63, no. 2, pp. 182–183, 2007. View at Google Scholar · View at Scopus
  25. R. H. Krech, V. Geenen, H. Maschek, and B. Högemann, “Adult giant cell hepatitis with fatal course. Clinical pathology case report and reflections on the pathogenesis,” Pathologe, vol. 19, no. 3, pp. 221–225, 1998. View at Publisher · View at Google Scholar · View at Scopus
  26. M. A. Khan, J. Ahn, N. Shah et al., “Fulminant hepatic failure in an adult patient with giant-cell hepatitis,” Gastroenterology and Hepatology, vol. 5, no. 7, pp. 502–504, 2009. View at Google Scholar
  27. L. Potenza, M. Luppi, P. Barozzi et al., “HHV-6A in syncytial giant-cell hepatitis,” The New England Journal of Medicine, vol. 359, no. 6, pp. 593–602, 2008. View at Publisher · View at Google Scholar · View at Scopus
  28. W. Kryczka, B. Walewska-Zielecka, and E. Dutkiewicz, “Acute seronegative hepatitis C manifesting itself as adult giant cell hepatitis: a case report and review of literature,” Medical Science Monitor, vol. 9, supplement 6, pp. 29–31, 2003. View at Google Scholar · View at Scopus
  29. S. T. L. Micchelli, D. Thomas, J. K. Boitnott, and M. Torbenson, “Hepatic giant cells in hepatitis C virus (HCV) mono-infection and HCV/HIV co-infection,” Journal of Clinical Pathology, vol. 61, no. 9, pp. 1058–1061, 2008. View at Publisher · View at Google Scholar · View at Scopus
  30. A. Moreno, A. Moreno, M. J. Pérez-Elías et al., “Syncytial giant cell hepatitis in human immunodeficiency virus-infected patients with chronic hepatitis C: 2 cases and review of the literature,” Human Pathology, vol. 37, no. 10, pp. 1344–1349, 2006. View at Publisher · View at Google Scholar · View at Scopus
  31. H. Thaler, “Post-infantile giant cell hepatitis,” Liver, vol. 2, no. 4, pp. 393–403, 1982. View at Google Scholar · View at Scopus
  32. N. Kerkar, D. Gold, S. N. Thung, and B. L. Shneider, “Jaundice accompanied by giant cell hepatitis and eosinophilia in childhood,” Seminars in Liver Disease, vol. 24, no. 1, pp. 107–111, 2004. View at Publisher · View at Google Scholar · View at Scopus
  33. M. Lazzarino, E. Orlandi, F. Baldanti et al., “The immunosuppression and potential for EBV reactivation of fludarabine combined with cyclophosphamide and dexamethasone in patients with lymphoproliferative disorders,” The British Journal of Haematology, vol. 107, no. 4, pp. 877–882, 1999. View at Google Scholar · View at Scopus
  34. C. J. Fimmel, L. Guo, R. W. Compans et al., “A case of syncytial giant cell hepatitis with features of a paramyxoviral infection,” The American Journal of Gastroenterology, vol. 93, no. 10, pp. 1931–1937, 1998. View at Publisher · View at Google Scholar · View at Scopus
  35. C. J. Fimmel and S. Robertazzi.., “Fulminant hepatic failure in an adult patient with giant-cell hepatitis,” Gastroenterology and Hepatology, vol. 5, no. 7, pp. 504–506, 2009. View at Google Scholar
  36. L. Falasca, F. D. Nonno, F. Palmieri et al., “Two cases of giant cell hepatitis in HIV-infected patients,” International Journal of STD & AIDS, vol. 23, no. 7, pp. 3–4, 2012. View at Google Scholar
  37. S. Welte, M. Gagesch, A. Weber et al., “Fulminant liver failure in Wilson's disease with histologic features of postinfantile giant cell hepatitis, cytomegalovirus as the trigger for both?” The European Journal of Gastroenterology and Hepatology, vol. 24, no. 3, pp. 328–331, 2012. View at Google Scholar
  38. A. Kumar and G. Y. Minuk, “Postinfantile giant cell hepatitis in association with hypereosinophilia,” Gastroenterology, vol. 101, no. 5, pp. 1417–1419, 1991. View at Google Scholar · View at Scopus
  39. E. Gupta, M. Yacoub, M. Higgins, and A. M. Al-Katib, “Syncytial giant cell hepatitis associated with chronic lymphocytic leukemia: a case report,” BMC Blood Disorders, vol. 19, article 8, no. 12, 2012. View at Google Scholar
  40. J. P. Lerut, N. Claeys, O. Ciccarelli et al., “Recurrent postinfantile syncytial giant cell hepatitis after orthotopic liver transplantation,” Transplant International, vol. 11, no. 4, pp. 320–322, 1998. View at Publisher · View at Google Scholar · View at Scopus
  41. O. Pappo, E. Yunis, J. A. Jordan et al., “Recurrent and de novo giant cell hepatitis after orthotopic liver transplantation,” The American Journal of Surgical Pathology, vol. 18, no. 8, pp. 804–813, 1994. View at Google Scholar · View at Scopus
  42. F. Durand, C. Degott, A. Sauvanet et al., “Subfulminant syncytial giant cell hepatitis: recurrence after liver transplantation treated with ribavirin,” Journal of Hepatology, vol. 26, no. 3, pp. 722–726, 1997. View at Publisher · View at Google Scholar · View at Scopus
  43. S. Nair, B. Baisden, J. Boitnott, A. Klein, and P. J. Thuluvath, “Recurrent, progressive giant cell hepatitis in two consecutive liver allografts in a middle-aged woman,” Journal of Clinical Gastroenterology, vol. 32, no. 5, pp. 454–456, 2001. View at Publisher · View at Google Scholar · View at Scopus
  44. J. C. Thijs, A. Bosma, S. C. Henzen-Logmans, and S. G. M. Meuwissen, “Postinfantile giant cell hepatitis in a patient with multiple autoimmune features,” The American Journal of Gastroenterology, vol. 80, no. 4, pp. 294–297, 1985. View at Google Scholar · View at Scopus
  45. O. Harmanci, I. K. Önal, O. Ersoy, B. Gürel, C. Sökmensüer, and Y. Bayraktar, “Post infantile giant cell hepatitis due to hepatitis E virus along with the presence of autoantibodies,” Digestive Diseases and Sciences, vol. 52, no. 12, pp. 3521–3523, 2007. View at Google Scholar
  46. A. Wasley, A. Fiore, and B. P. Bell, “Hepatitis A in the era of vaccination,” Epidemiologic Reviews, vol. 28, no. 1, pp. 101–111, 2006. View at Publisher · View at Google Scholar · View at Scopus
  47. G. Koukoulis, G. Mieli-Vergani, and B. Portmann, “Infantile liver giant cells: immunohistological study of their proliferative state and possible mechanisms of formation,” Pediatric and Developmental Pathology, vol. 2, no. 4, pp. 353–359, 1999. View at Publisher · View at Google Scholar · View at Scopus
  48. K. Aterman, “Neonatal hepatitis and its relation to viral hepatitis of mother. A review of the problem,” The American Journal of Diseases of Children, vol. 105, pp. 395–416, 1963. View at Google Scholar · View at Scopus
  49. E. Roberts, E. L. Ford-Jones, and M. J. Phillips, “Ribavirin for syncytial giant cell hepatitis,” The Lancet, vol. 341, no. 8845, pp. 640–641, 1993. View at Google Scholar · View at Scopus
  50. H. P. . Dienes, U. Protzer, G. Gerken et al., “Pathogenesis and clinical relevance of post infantile giant cell hepatitis (PIGCH),” Hepatology, vol. 18, article 175A, 1993. View at Google Scholar
  51. Y. Horsmans, C. Galant, M. L. Nicholas, M. Lamy, and A. P. Geubel, “Failure of ribavarin or immunosupressive therapy to alter the course of post-inflantile giant-cell hepatitis,” Journal of Hepatology, vol. 22, article 382, no. 3, 1995. View at Publisher · View at Google Scholar · View at Scopus
  52. A. J. Czaja and D. K. Freese, “Diagnosis and treatment of autoimmune hepatitis,” Hepatology, vol. 36, no. 2, pp. 479–497, 2002. View at Publisher · View at Google Scholar · View at Scopus
  53. L. Bianchi and L. M. Terracciano, “Giant cell hepatitis in adult,” Praxis, vol. 83, no. 44, pp. 1237–1241, 1994. View at Google Scholar